CS logo
small CS logo
Klinik Schillerhöhe

Gerlingen, Germany
Allgemeinkrankenhaus in Gerlingen, Baden-Württemberg

About Klinik Schillerhöhe


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Klinik Schillerhöhe


During the past decade, Klinik Schillerhöhe conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
2011-04-01
2023-07-01
Active, not recruiting
1,545
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
2011-01-06
Active, not recruiting
3,270
A Study Comparing Obinutuzumab (RO5072759; GA101) 1000 Milligram (mg) Versus 2000 mg in Participants With Previously Untreated Chronic Lymphocytic Leukemia (CLL) (GAGE)
2011-10-31
2016-03-31
Completed
80
PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery
2012-06-12
2023-06-30
Active, not recruiting
1,194
Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
2012-04-01
2023-11-01
Active, not recruiting
1,871
An Observational Study in Patients With HER2 Positive Metastatic Breast Cancer (SystHERs Registry)
2012-06-05
2017-11-16
Completed
1,007
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
2013-04-01
2030-01-01
Active, not recruiting
1,900
A Study of Weekly Carfilzomib in Combination With Dexamethasone for Progressive Multiple Myeloma
2012-07-04
2018-10-31
Completed
116

Rows per page:

1–69 of 69

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Klinik Schillerhöhe" #1 sponsor was "Janssen Research & Development, LLC" with 2 trials, followed by "AIO-Studien-gGmbH" with 1 trials sponsored, "Chimerix" with 1 trials sponsored, "FibroGen" with 1 trials sponsored and "Hannover Medical School" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Klinik Schillerhöhe" #1 collaborator was "AstraZeneca" with 2 trials as a collaborator, "Assistance Publique - Hôpitaux de Paris" with 1 trials as a collaborator, "Celgene" with 1 trials as a collaborator, "Charite University, Berlin, Germany" with 1 trials as a collaborator and "German Cancer Research Center" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Klinik Schillerhöhe


According to Clinical.Site data, the most researched conditions in "Klinik Schillerhöhe" are "Carcinoma, Non-Small-Cell Lung" (3 trials), "Bacterial Pneumonia" (1 trials), "COVID-19" (1 trials), "Cancers With DNA Repair-Deficiency" (1 trials) and "Chronic Obstructive Pulmonary Disease" (1 trials). Many other conditions were trialed in "Klinik Schillerhöhe" in a lesser frequency.

Clinical Trials Intervention Types at Klinik Schillerhöhe


Most popular intervention types in "Klinik Schillerhöhe" are "Drug" (8 trials), "Procedure" (2 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Amivantamab" (2 trials), "Carboplatin" (2 trials), "Lazertinib" (2 trials), "Placebo" (2 trials) and "Brigatinib" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Klinik Schillerhöhe


The vast majority of trials in "Klinik Schillerhöhe" are 12 trials for "All" genders.

Clinical Trials Status at Klinik Schillerhöhe


Currently, there are NaN active trials in "Klinik Schillerhöhe". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Klinik Schillerhöhe, undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Klinik Schillerhöhe, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status